The m.5702A>G variant in MT-TN has been reported in one individual with primary mitochondrial disease to date (PMID: 32161153; this appears to be the same individual reported in an abstract, https://www.nmd-journal.com/article/S0960-8966(16)30622-8/abstract, and included in the ClinVar submission for this variant). Clinical features in this woman include ophthalmoplegia, ptosis, myopathy, and ragged red and COX-negative fibers on muscle biopsy. The variant is present in the proband at 60% heteroplasmy muscle, 10% in urine, and absent in blood and skin fibroblasts. The variant is absent in blood and urine from her mother and four asymptomatic siblings (PM6_supporting; https://www.nmd-journal.com/article/S0960-8966(16)30622-8/abstract). There are no additional individuals or families reported with de novo occurrences of this variant or with this variant segregating with clinical manifestations to our knowledge. This variant is absent in the GenBank dataset, Helix dataset, and gnomAD v3.1.2 (PM2_supporting). Computational predictors are conflicting (MitoTIP: 73.9%; HmtVAR: 0.05). There are no cybrids, single fiber studies, or other functional assays reported on this variant. In summary, this variant meets criteria to be classified as uncertain significance for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on September 24, 2024. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID: 32906214): PM6_supporting, PM2_supporting.